When alliances fail, is arbitration the answer?
The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy
- Growing pains 03-08-2021
- CRISPR: A licence to heal 01-10-2019
- Brexit: The waiting game 01-10-2019
- IP portfolios: the five biggest headaches for in-house counsel 30-09-2019
- Genetic research: DNA payday 30-09-2019
Latest genetics news
BGI hit with $8m damages bill in patent dispute with Illumina
02-12-2021
Illumina has secured an $8 million damages verdict against China-based BGI Genomics, and its US subsidiary, MGI, in a dispute involving gene-sequencing patents.
